126 related articles for article (PubMed ID: 12534000)
1. [Efficacy trial in general practice substantiated. New antibiotic with strong effectiveness and tolerance].
MMW Fortschr Med; 2002 Oct; 144(42):60-1. PubMed ID: 12534000
[No Abstract] [Full Text] [Related]
2. [Telithromycin: a new therapeutic option for community-acquired respiratory infection].
Muñoz MJ; Azanza JR; Escolar M; Macaya A; Gil FJ
Rev Med Univ Navarra; 2002; 46(3):37-44. PubMed ID: 12685116
[No Abstract] [Full Text] [Related]
3. [Resistance of respiratory tract infection agents is still increasing. Is its time for new antibiotic strategies?].
MMW Fortschr Med; 2003 Feb; 145(9):55. PubMed ID: 12666535
[No Abstract] [Full Text] [Related]
4. [Importance in respiratory tract infections. Ketolides: clinical aspects].
Lorenz J; Steiert P
Pharm Unserer Zeit; 2004; 33(1):42-6. PubMed ID: 14968712
[No Abstract] [Full Text] [Related]
5. Clinical efficacy of ketolides in the treatment of respiratory tract infections.
Reinert RR
J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of respiratory tract infections in the community: experience with telithromycin.
Quintiliani R
Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
[TBL] [Abstract][Full Text] [Related]
7. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
Carter PL
Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
[TBL] [Abstract][Full Text] [Related]
8. [Acute respiratory tract infection in chronically ill patients. germ spectrum different than in healthy persons].
MMW Fortschr Med; 2003 Dec; 145(49):61. PubMed ID: 14964003
[No Abstract] [Full Text] [Related]
9. [A new antibiotic against respiratory tract infections. More power against pneumococci].
MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
[No Abstract] [Full Text] [Related]
10. [Telithromycin in the management of lower respiratory tract infections in the hospital].
Léophonte P
Presse Med; 2003 Jun; 32(20):952-3. PubMed ID: 12876542
[No Abstract] [Full Text] [Related]
11. Telithromycin (Ketek) for respiratory infections.
Med Lett Drugs Ther; 2004 Aug; 46(1189):66-8. PubMed ID: 15314586
[No Abstract] [Full Text] [Related]
12. Cost-effectiveness of macrolides in lower respiratory tract infections.
Dietrich ES; Voegele T; Frank U; Daschner FD
Ann Pharmacother; 1999 Oct; 33(10):1125-6. PubMed ID: 10534230
[No Abstract] [Full Text] [Related]
13. A pooled analysis of telithromycin in the treatment of community-acquired respiratory tract infections in adults.
Carbon C
Infection; 2003 Oct; 31(5):308-17. PubMed ID: 14556055
[TBL] [Abstract][Full Text] [Related]
14. [Bacterial airway infections. Standard antibiotics more often ineffective].
MMW Fortschr Med; 2002 Feb; 144(8):52. PubMed ID: 11910829
[No Abstract] [Full Text] [Related]
15. [Are ketolides replacing macrolides in chronic bronchitis?].
Adam D
Internist (Berl); 2002 Jul; 43(7):887-8. PubMed ID: 12219690
[No Abstract] [Full Text] [Related]
16. Telithromycin.
Raja A; Lebbos J; Kirkpatrick P
Nat Rev Drug Discov; 2004 Sep; 3(9):733-4. PubMed ID: 15368658
[No Abstract] [Full Text] [Related]
17. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections.
Lorenz J
Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892
[TBL] [Abstract][Full Text] [Related]
18. [Miocamycin: multicenter clinical study in patients with bacterial infections of the upper respiratory tract].
Marni E; Salvatoni A; Martignoni L; Visantino S; Binda S
G Ital Chemioter; 1987; 34(1-3):63-71. PubMed ID: 3332870
[No Abstract] [Full Text] [Related]
19. [Clinical effectiveness of antibacterial drug rulicin in pyo-inflammatory diseases of the upper airways].
Luchikhin LA; Kononova NA
Vestn Otorinolaringol; 2003; (3):41-3. PubMed ID: 12847807
[No Abstract] [Full Text] [Related]
20. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M
J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
